ABVX Relative Valuation
ABVX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ABVX is overvalued; if below, it's undervalued.
Historical Valuation
Abivax SA (ABVX) is now in the Fair zone, suggesting that its current forward PS ratio of 336.55 is considered Fairly compared with the five-year average of -7.99. The fair price of Abivax SA (ABVX) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price：110.64
Fair
-33.77
PE
1Y
3Y
5Y
Trailing
Forward
-37.39
EV/EBITDA
Abivax SA. (ABVX) has a current EV/EBITDA of -37.39. The 5-year average EV/EBITDA is -13.31. The thresholds are as follows: Strongly Undervalued below -68.73, Undervalued between -68.73 and -41.02, Fairly Valued between 14.40 and -41.02, Overvalued between 14.40 and 42.11, and Strongly Overvalued above 42.11. The current Forward EV/EBITDA of -37.39 falls within the Historic Trend Line -Fairly Valued range.
-44.67
EV/EBIT
Abivax SA. (ABVX) has a current EV/EBIT of -44.67. The 5-year average EV/EBIT is -13.05. The thresholds are as follows: Strongly Undervalued below -68.14, Undervalued between -68.14 and -40.60, Fairly Valued between 14.49 and -40.60, Overvalued between 14.49 and 42.04, and Strongly Overvalued above 42.04. The current Forward EV/EBIT of -44.67 falls within the Undervalued range.
336.55
PS
Abivax SA. (ABVX) has a current PS of 336.55. The 5-year average PS is 270.58. The thresholds are as follows: Strongly Undervalued below -1103.24, Undervalued between -1103.24 and -416.33, Fairly Valued between 957.50 and -416.33, Overvalued between 957.50 and 1644.41, and Strongly Overvalued above 1644.41. The current Forward PS of 336.55 falls within the Historic Trend Line -Fairly Valued range.
-47.52
P/OCF
Abivax SA. (ABVX) has a current P/OCF of -47.52. The 5-year average P/OCF is -1.09. The thresholds are as follows: Strongly Undervalued below -82.87, Undervalued between -82.87 and -41.98, Fairly Valued between 39.80 and -41.98, Overvalued between 39.80 and 80.69, and Strongly Overvalued above 80.69. The current Forward P/OCF of -47.52 falls within the Undervalued range.
-68.44
P/FCF
Abivax SA. (ABVX) has a current P/FCF of -68.44. The 5-year average P/FCF is -0.73. The thresholds are as follows: Strongly Undervalued below -117.09, Undervalued between -117.09 and -58.91, Fairly Valued between 57.45 and -58.91, Overvalued between 57.45 and 115.62, and Strongly Overvalued above 115.62. The current Forward P/FCF of -68.44 falls within the Undervalued range.
Abivax SA (ABVX) has a current Price-to-Book (P/B) ratio of -124.67. Compared to its 3-year average P/B ratio of -16.03 , the current P/B ratio is approximately 677.91% higher. Relative to its 5-year average P/B ratio of -2.03, the current P/B ratio is about 6051.90% higher. Abivax SA (ABVX) has a Forward Free Cash Flow (FCF) yield of approximately -1.86%. Compared to its 3-year average FCF yield of -19.79%, the current FCF yield is approximately -90.59% lower. Relative to its 5-year average FCF yield of -16.20% , the current FCF yield is about -88.50% lower.
-124.67
P/B
Median3y
-16.03
Median5y
-2.03
-1.86
FCF Yield
Median3y
-19.79
Median5y
-16.20
Competitors Valuation Multiple
The average P/S ratio for ABVX's competitors is 168.28, providing a benchmark for relative valuation. Abivax SA Corp (ABVX) exhibits a P/S ratio of 336.55, which is 100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ABVX increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ABVX in the past 1 year is driven by Unknown.
People Also Watch
FAQ
Is Abivax SA (ABVX) currently overvalued or undervalued?
What is Abivax SA (ABVX) fair value?
How does ABVX's valuation metrics compare to the industry average?
What is the current P/B ratio for Abivax SA (ABVX) as of Dec 05 2025?
What is the current FCF Yield for Abivax SA (ABVX) as of Dec 05 2025?
What is the current Forward P/E ratio for Abivax SA (ABVX) as of Dec 05 2025?